Citations

Showing 10 of 108119 citations.

Signaling hostility: The relationship between witnessing weight‐based discrimination in medical school and medical student well‐being
Meadows, Angela , Barreto, Manuela , Dovidio, John F. , Burke, Sara E. , Wittlin, Natalie M. , Herrin, Jeph , Ryn, Michelle van , Phelan, Sean M. , Phelan, S M , Herrin, Jeph , van Ryn, Michelle

Mayo Clinic

Journal of Applied Social Psychology | December 16, 2021 | Volume: 53 | Issue: 3 | Pages: 215-230

10.1111/jasp.12847 Get It

AbstractEnvironments that are hostile to one or more marginalized groups are known to have a negative effect on the mental health and well‐being of both targets and observers. Anti‐fat attitudes have been well documented in medical education, including the use of derogatory humor and discriminatory treatment toward higher‐weight patients. However, to date, it is not known what effect observing weight stigma and discrimination during medical school has on medical students’ psychological health and wellbeing, sense of belonging, and medical school burnout. The present study surveyed a total of 3994 students enrolled across 49 US medical schools at the start of their first year and at the end of their fourth year. Participants reported the frequency with which they had observed stigmatizing and discriminatory behaviors targeted at both higher‐weight patients and higher‐weight students during their four years of medical school. Observed weight stigma was prevalent, and was associated with worse psychological and general health, reduced medical school belonging and increased medical school burnout. The indirect effects of observed weight stigma on medical school burnout, via belonging, psychological health, and general health, were statistically significant in the sample as a whole, but were more pronounced in higher‐weight students. This effect may be explained, in part, by the relationship between observed stigma and medical school belonging. Higher levels of observed stigma were associated with reduced feelings of belonging in higher‐weight but not normative‐weight students. Top‐down institutional culture change is needed to rectify this situation, which is detrimental to both students and patients.
Allograft prosthetic composite reconstruction using a reverse total shoulder arthroplasty for failed oncologic proximal humerus reconstruction
Houdek, Matthew T. , Rose, Peter S. , Elhassan, Bassem T. , Barlow, Jonathan D. , Sanchez-Sotelo, Joaquin, Houdek, Matthew T , Wagner, Eric R. , Elhassan, Bassem T. , Sánchez‐Sotelo, Joaquín

Mayo Clinic

Journal of Surgical Oncology | December 16, 2021 | Volume: 125 | Issue: 4 | Pages: 775-781

10.1002/jso.26772 | PMID 34913481 Get It

AbstractIntroductionEndoprosthetic or allograft reconstruction are the preferred reconstruction techniques for proximal humeral bone tumors. Failure of these reconstructions may occur, but historically revision is performed rarely due to the lack of reliable options. Reverse shoulder arthroplasty with an allograft prosthetic composite (rAPC) may provide a revision option. The purpose of the current study was to evaluate our institutional outcome of these procedures.MethodsEleven (6 male, 5 female) patients (mean age 51 ± 17 years) underwent revision of a failed oncologic reconstruction of the proximal humerus utilizing a rAPC. The most common indication for revision was subluxation (n = 6) and the most common previous implant was an endoprosthesis (n = 5).ResultsRevision resulted in improvements in shoulder elevation (39° vs. 62°, p = 0.02), external rotation (13° vs. 25°, p = 0.04), American Shoulder and Elbow Surgeons score (39 vs. 58, p = 0.004) and Musculoskeletal Tumor Society Scores (51% vs 69%, p = 0.002). There were 2 re‐revision procedures performed. One for an allograft fracture and one for allograft resorption and loosening.ConclusionsRevision with a rAPC can effectively restore patient function. Due to the complexity of the cases, we advocate for these procedures to be performed by subspecialty upper extremity surgeons trained in complex revision shoulder arthroplasty.
Detection of Left Atrial Myopathy Using Artificial Intelligence–Enabled Electrocardiography
Verbrugge, Frederik H. , Reddy, Yogesh N.V. , Attia, Zachi I. , Friedman, Paul A. , Noseworthy, Peter A. , López-Jiménez, Francisco , Borlaug, Barry A. , Kapa, Suraj , Borlaug, Barry A , Noseworthy, Peter A , Nishimura, Rick , Lopez-Jimenez, Francisco , Attia, Zachi I , Verbrugge, Frederik H , Kapa, Suraj

Mayo Clinic

Circulation: Heart Failure | December 16, 2021 | Volume: 15 | Issue: 1 | Pages: No page available

10.1161/circheartfailure.120.008176 | PMID 34911362 Get It

Background: Left atrial (LA) myopathy is common in patients with heart failure and preserved ejection fraction and leads to the development of atrial fibrillation (AF). We investigated whether the likelihood of LA remodeling, LA dysfunction, altered hemodynamics, and risk for incident AF could be identified from a single 12-lead ECG using a novel artificial intelligence (AI)-enabled ECG analysis. Methods: Patients with heart failure and preserved ejection fraction (n=613) underwent AI-enabled ECG analysis, echocardiography, and cardiac catheterization. Individuals were grouped by AI-enabled ECG probability of contemporaneous AF, taken as an indicator of underlying LA myopathy. Results: Structural heart disease was more severe in patients with higher AI-probability of AF, with more left ventricular hypertrophy, larger LA volumes, and lower LA reservoir and booster strain. Cardiac filling pressures and pulmonary artery pressures were higher in patients with higher AI-probability, while cardiac output reserve was more impaired during exercise. Among patients with sinus rhythm and no prior AF, each 10% increase in AI-probability was associated with a 31% greater risk of developing new-onset AF (hazard ratio, 1.31 [95% CI, 1.20–1.42]; P <0.001). In the population as a whole, each 10% increase in AI-probability was associated with a 12% greater risk of death (hazard ratio, 1.12 [95% CI, 1.08–1.17]; P <0.001) during long-term follow-up, which was no longer significant after adjustments for baseline characteristics. Conclusions: A novel AI-enabled score derived from a single 12-lead ECG identifies the presence of underlying LA myopathy in patients with heart failure and preserved ejection fraction as evidenced by structural, functional, and hemodynamic abnormalities, as well as long-term risk for incident AF. Further research is required to determine the role of the AI-enabled ECG in the evaluation and care of patients with heart failure and preserved ejection fraction.
In Reply: A New Trend of Blended Learning in Neurosurgical Training: Fellowship of Neuroendoscopy
Azzam, Ahmed Y., Ghozy, Sherief , Ghozy, Sherief , Azzam, Ahmed Y.

Mayo Clinic

Neurosurgery | December 16, 2021 | Volume: 90 | Issue: 2 | Pages: e55-e56

10.1227/neu.0000000000001806 | PMID 34995236 Get It

Self-Dilation of Refractory Benign Esophageal Strictures
Kahn, Allon , Halland, Magnus , Fleischer, David E., Kahn, Allon

Mayo Clinic

American Journal of Gastroenterology | December 16, 2021 | Volume: 117 | Issue: 3 | Pages: 364-366

10.14309/ajg.0000000000001589 | PMID 34913874 Get It

Neuropathology of McLeod Syndrome
Deutschländer, Angela , Deutschländer, Angela B , Dickson, Dennis W. , Wszołek, Zbigniew K.

Mayo Clinic

Movement Disorders | December 16, 2021 | Volume: 37 | Issue: 3 | Pages: 644-646

10.1002/mds.28882 | PMID 34913196 Get It

COVLIAS 1.0 vs. MedSeg: Artificial Intelligence-Based Comparative Study for Automated COVID-19 Computed Tomography Lung Segmentation in Italian and Croatian Cohorts
Suri, Jasjit S. , Agarwal, Sushant , Carriero, Alessandro , Paschè, Alessio , Danna, Pietro , Columbu, Marta, Saba, Luca , Višković, Klaudija , Mehmedović, Armin , Agarwal, Samriddhi, Gupta, Lakshya, Faa, Gavino , Singh, Inder M. , Turk, Monika, Chadha, Paramjit S., Johri, Amer M. , Khanna, Narendra N. , Laird, John R. , Pareek, Gyan , Miner, Martin , Sobel, David , Balestrieri, Antonella , Sfikakis, Petros P. , Tsoulfas, George, Protogerou, Athanase D. , Misra, Durga Prasanna , Agarwal, Vikas , Teji, Jagjit S. , Al-Maini, Mustafa , Dhanjil, Surinder, Rathore, Vijay , Fatemi, Mostafa , Krishnan, Pudukode R., Nagy, F. , Ruzsa, Zoltán , Naidu, Subbaram , Paraskevas, Kosmas I. , Danna, Pietro S C , Tsoulfas, George , Protogerou, Athanasios , Fatemi, Mostafa , Alizad, Azra , Ferenc, Nagy , Ruzsa, Zoltan , Paraskevas, Kosmas I , Misra, Durga Prasanna , Agarwal, Vikas , Faa, Gavino , Mehmedović, Armin , Agarwal, Sushant , Suri, Jasjit S. , Saba, Luca , Mavrogeni, Sophie , Kitas, George D. , Nicolaides, Andrew , Sharma, Aditya , Alizad, Azra , Gupta, Archna , Kalra, Mannudeep K.

Mayo Clinic

Diagnostics | December 15, 2021 | Volume: 11 | Issue: 12 | Pages: 2367

10.3390/diagnostics11122367 | PMID 34943603 Get It

(1) Background: COVID-19 computed tomography (CT) lung segmentation is critical for COVID lung severity diagnosis. Earlier proposed approaches during 2020–2021 were semiautomated or automated but not accurate, user-friendly, and industry-standard benchmarked. The proposed study compared the COVID Lung Image Analysis System, COVLIAS 1.0 (GBTI, Inc., and AtheroPointTM, Roseville, CA, USA, referred to as COVLIAS), against MedSeg, a web-based Artificial Intelligence (AI) segmentation tool, where COVLIAS uses hybrid deep learning (HDL) models for CT lung segmentation. (2) Materials and Methods: The proposed study used 5000 ITALIAN COVID-19 positive CT lung images collected from 72 patients (experimental data) that confirmed the reverse transcription-polymerase chain reaction (RT-PCR) test. Two hybrid AI models from the COVLIAS system, namely, VGG-SegNet (HDL 1) and ResNet-SegNet (HDL 2), were used to segment the CT lungs. As part of the results, we compared both COVLIAS and MedSeg against two manual delineations (MD 1 and MD 2) using (i) Bland–Altman plots, (ii) Correlation coefficient (CC) plots, (iii) Receiver operating characteristic curve, and (iv) Figure of Merit and (v) visual overlays. A cohort of 500 CROATIA COVID-19 positive CT lung images (validation data) was used. A previously trained COVLIAS model was directly applied to the validation data (as part of Unseen-AI) to segment the CT lungs and compare them against MedSeg. (3) Result: For the experimental data, the four CCs between COVLIAS (HDL 1) vs. MD 1, COVLIAS (HDL 1) vs. MD 2, COVLIAS (HDL 2) vs. MD 1, and COVLIAS (HDL 2) vs. MD 2 were 0.96, 0.96, 0.96, and 0.96, respectively. The mean value of the COVLIAS system for the above four readings was 0.96. CC between MedSeg vs. MD 1 and MedSeg vs. MD 2 was 0.98 and 0.98, respectively. Both had a mean value of 0.98. On the validation data, the CC between COVLIAS (HDL 1) vs. MedSeg and COVLIAS (HDL 2) vs. MedSeg was 0.98 and 0.99, respectively. For the experimental data, the difference between the mean values for COVLIAS and MedSeg showed a difference of <2.5%, meeting the standard of equivalence. The average running times for COVLIAS and MedSeg on a single lung CT slice were ~4 s and ~10 s, respectively. (4) Conclusions: The performances of COVLIAS and MedSeg were similar. However, COVLIAS showed improved computing time over MedSeg.
Duration of Care and Operative Time Are the Primary Drivers of Total Charges After Ambulatory Hip Arthroscopy: A Machine Learning Analysis
Lu, Yining , Lavoie‐Gagne, Ophelie , Pareek, Ayoosh , Kunze, Kyle N. , Forsythe, Brian , Levy, Bruce A. , Krych, Aaron J. , Lu, Yining , Krych, Aaron J , Forsythe, Brian , Forlenza, Enrico M.

Mayo Clinic

Arthroscopy | December 15, 2021 | Volume: 38 | Issue: 7 | Pages: 2204

10.1016/j.arthro.2021.12.012 | PMID 34921955 Get It

Purpose To develop a machine learning algorithm to predict total charges after ambulatory hip arthroscopy and create a risk‐adjusted payment model based on patient comorbidities. Methods A retrospective review of the New York State Ambulatory Surgery and Services database was performed to identify patients who underwent elective hip arthroscopy between 2015 and 2016. Features included in initial models consisted of patient characteristics, medical comorbidities, and procedure‐specific variables. Models were generated to predict total charges using 5 algorithms. Model performance was assessed by the root‐mean‐square error, root‐mean‐square logarithmic error, and coefficient of determination. Global variable importance and partial dependence curves were constructed to show the impact of each input feature on total charges. For performance benchmarking, the best candidate model was compared with a multivariate linear regression using the same input features. Results A total of 5,121 patients were included. The median cost after hip arthroscopy was $19,720 (interquartile range, $12,399‐$26,439). The gradient‐boosted ensemble model showed the best performance (root‐mean‐square error, $3,800 [95% confidence interval, $3,700‐$3,900]; logarithmic root‐mean‐square error, 0.249 [95% confidence interval, 0.24‐0.26]; R 2 = 0.73). Major cost drivers included total hours in facility less than 12 or more than 15, longer procedure time, performance of a labral repair, age younger than 30 years, Elixhauser Comorbidity Index (ECI) of 1 or greater, African American race, residence in extreme urban and rural areas, and higher household and neighborhood income. Conclusions The gradient‐boosted ensemble model effectively predicted total charges after hip arthroscopy. Few modifiable variables were identified other than anesthesia type; nonmodifiable drivers of total charges included duration of care less than 12 hours or more than 15 hours, operating room time more than 100 minutes, age younger than 30 years, performance of a labral repair, and ECI greater than 0. Stratification of patients based on the ECI highlighted the increased financial risk borne by physicians via flat reimbursement schedules given variable degrees of comorbidities. Level of Evidence Level III, retrospective cohort study.
Pathology in Practice
Gades, Naomi M. , Moe, Larry B., Waldron, Roberta L., McNeill, Darin J., Bëlohlávek, Marek

Mayo Clinic

Journal of the American Veterinary Medical Association | December 15, 2021 | Volume: 259 | Issue: S2 | Pages: 1-3

10.2460/javma.19.05.0214 | PMID 34910671 Get It

Abstract In collaboration with the American College of Veterinary Pathologists
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
León, José de , Schoretsanitis, Georgios , Smith, Robert L. , Molden, Espen , Solismaa, Anssi , Seppälä, Niko , Kopeček, Miloslav , Švancer, Patrik , Olmos, I. Cánovas , Ricciardi, Carina , García, Celso Iglesias , Iglesias-Alonso, Ana , Ruan, Can‐Jun , Wang, Chuanyue , Wang, Gang , Tang, Yi‐lang , Kim, Yong Sik , Kim, Se Hyun , Rajkumar, Anto P. , González‐Esquivel, Dinora F. , Jung–Cook, Helgi , Verdoux, Hélène , Quilès, Clélia , Sanz, Emílio J. , Cuevas, Carlos De las , Cohen, Dan , Schulte, Peter F.J. , Yağcıoğlu, A. Elif Anıl , Chopra, Nitin , McCollum, Betsy , Shelton, Charles , Cotes, Robert O. , Kaithi, Arun R., Kane, John M. , Farooq, Saeed , Ng, Chee H. , Bilbily, John , Hiemke, Christoph , López‐Jaramillo, Carlos , McGrane, Ian R. , Lana, Fernando , Arrojo, Manuel , Rădulescu, Flavian Ștefan , Seifritz, Erich , Every‐Palmer, Susanna , Bebawi, Emmanuel , Bhattacharya, Rahul , Kelly, Deanna L. , Otsuka, Yuji , Lazáry, Judit , Torres, Rafael , Yécora, Agustín, Motuca, Mariano , Chan, Sherry Kit Wa , Berardis, Domenico De , Adebayo, Richard A. , Кирилочев, О.О. , Soloviev, A. G. , Fountoulakis, Konstantinos Ν. , Wilkowska, Alina , Cubała, Wiesław Jerzy , Ayub, Muhammad , Silva, Alzira , Bonelli, Raphael M., Crespo‐Facorro, Benedicto , Temmingh, Henk , Decloedt, Eric , Pedro, Maria Rosel , Tsukahara, Masaru , Gründer, Gerhard , Čelofiga, Andreja , Ristić, Dragana Ignjatović , Ortiz, Bruno Bertolucci , Elkis, Hélio , Siskind, Dan , Masmoudi, R. , Saffian, Shamin Mohd , Leung, Jonathan G. , Buckley, P.F. , Freudenreich, Oliver , Müller, Daniel J. , de Leon, Jose , Olmos, Ismael , Iglesias-Garcia, Celso , Spina, Edoardo , Ruan, Can-Jun , Wang, Chuan-Yue , Tang, Yi-Lang , Lin, Shih-Ku , Lane, Hsien-Yuan , Kim, Yong Sik , Kim, Se Hyun , Rajkumar, Anto P , González-Esquivel, Dinora F , Jung-Cook, Helgi , Baptista, Trino , Rohde, Christopher , Nielsen, Jimmi , Verdoux, Hélène , Quiles, Clelia , Sanz, Emilio J , De Las Cuevas, Carlos , Cohen, Dan , Schulte, Peter F J , Ertuğrul, Aygün , Anıl Yağcıoğlu, A Elif , Chopra, Nitin , McCollum, Betsy , Shelton, Charles , Cotes, Robert O , Kane, John M , Farooq, Saeed , Ng, Chee H , Bilbily, John , Hiemke, Christoph , López-Jaramillo, Carlos , McGrane, Ian , Lana, Fernando , Eap, Chin B , Every-Palmer, Susanna , Bousman, Chad A , Bebawi, Emmanuel , Bhattacharya, Rahul , Kelly, Deanna L , Otsuka, Yuji , Lazary, Judit , Motuca, Mariano , Chan, Sherry K W , Zolezzi, Monica , Ouanes, Sami , De Berardis, Domenico , Grover, Sandeep , Procyshyn, Ric M , Adebayo, Richard A , Kirilochev, Oleg O , Soloviev, Andrey , Fountoulakis, Konstantinos N , Wilkowska, Alina , Cubała, Wiesław J , Ayub, Muhammad , Silva, Alzira , Villagrán-Moreno, José M , Crespo-Facorro, Benedicto , Temmingh, Henk , Decloedt, Eric , Pedro, Maria R , Takeuchi, Hiroyoshi , Tsukahara, Masaru , Gründer, Gerhard , Sagud, Marina , Celofiga, Andreja , Ignjatovic Ristic, Dragana , Ortiz, Bruno B , Elkis, Helio , Pacheco Palha, António J , LLerena, Adrián , Fernandez-Egea, Emilio , Siskind, Dan , Weizman, Abraham , Masmoudi, Rim , Mohd Saffian, Shamin , Leung, Jonathan G , Buckley, Peter F , Marder, Stephen R , Citrome, Leslie , Freudenreich, Oliver , Correll, Christoph Ulrich , Müller, Daniel J , Kopecek, Miloslav , Arrojo-Romero, Manuel , Schoretsanitis, Georgios , Rohde, Christopher , Nielsen, Jimmi , Bousman, Chad , LLerena, Adrián , Citrome, Leslie

Mayo Clinic

Pharmacopsychiatry | December 15, 2021 | Volume: 55 | Issue: 02 | Pages: 73-86

10.1055/a-1625-6388 | PMID 34911124 Get It

Abstract This international guideline proposes improving clozapine package inserts worldwide by using ancestry-based dosing and titration. Adverse drug reaction (ADR) databases suggest that clozapine is the third most toxic drug in the United States (US), and it produces four times higher worldwide pneumonia mortality than that by agranulocytosis or myocarditis. For trough steady-state clozapine serum concentrations, the therapeutic reference range is narrow, from 350 to 600 ng/mL with the potential for toxicity and ADRs as concentrations increase. Clozapine is mainly metabolized by CYP1A2 (female non-smokers, the lowest dose; male smokers, the highest dose). Poor metabolizer status through phenotypic conversion is associated with co-prescription of inhibitors (including oral contraceptives and valproate), obesity, or inflammation with C-reactive protein (CRP) elevations. The Asian population (Pakistan to Japan) or the Americas’ original inhabitants have lower CYP1A2 activity and require lower clozapine doses to reach concentrations of 350 ng/mL. In the US, daily doses of 300–600 mg/day are recommended. Slow personalized titration may prevent early ADRs (including syncope, myocarditis, and pneumonia). This guideline defines six personalized titration schedules for inpatients: 1) ancestry from Asia or the original people from the Americas with lower metabolism (obesity or valproate) needing minimum therapeutic dosages of 75–150 mg/day, 2) ancestry from Asia or the original people from the Americas with average metabolism needing 175–300 mg/day, 3) European/Western Asian ancestry with lower metabolism (obesity or valproate) needing 100–200 mg/day, 4) European/Western Asian ancestry with average metabolism needing 250–400 mg/day, 5) in the US with ancestries other than from Asia or the original people from the Americas with lower clozapine metabolism (obesity or valproate) needing 150–300 mg/day, and 6) in the US with ancestries other than from Asia or the original people from the Americas with average clozapine metabolism needing 300–600 mg/day. Baseline and weekly CRP monitoring for at least four weeks is required to identify any inflammation, including inflammation secondary to clozapine rapid titration.